Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals
A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- Study Affirms Bitter Orange Has No Impact on Blood Pressure
Results from the double-blind, randomized, placebo-controlled, crossover study, appear in the Winter 2005 issue of Pharmacotherapy, measured the rate-corrected QT (QTc) interval and blood pressure before dosing subjects with bitter orange extract or placebo and then again at one, three, five and eight hours after dosing.
- Study Affirms Bitter Orange Has No Impact on Blood Pressure
Results from the double-blind, randomized, placebo-controlled, crossover study, appear in the Winter 2005 issue of Pharmacotherapy, measured the rate-corrected QT (QTc) interval and blood pressure before dosing subjects with bitter orange extract or placebo and then again at one, three, five and eight hours after dosing.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Biogaia Releases Results From Allergy Study
Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
|
NORTHBROOK, Ill., Dec 12, 2005 /PRNewswire via COMTEX/ -- Vitamin D may play a role in keeping our lungs healthy, with greater concentrations of vitamin D resulting in greater lung health benefits. A study in the December issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D. "Low levels of vitamin D have been associated with osteoporosis, hypertension, diabetes, and cancer," said lead author Peter Black, MB, ChB, Department of Medicine, University of Auckland, Auckland, New Zealand. "Our research shows that vitamin D may also have a strong influence on lung health, with greater levels of vitamin D associated with greater and more positive effects on lung function."
Researchers from the University of Auckland examined the relationship between vitamin D and lung function using participants from the United States National Health and Nutrition Examination Survey (NHANES III) carried out during 1988 to 1994. The study included 14,091 people aged greater than or equal to 20 years, who were interviewed at mobile examination centers, had spirometry performed, and had serum 25-hydroxyvitamin D measured. Vitamin D measurements were divided into five groups (quintiles), ranging from more than 85.7 mL to less than 40.4 mL. After adjusting for gender, age, ethnicity, body mass index, and smoking status, the differences between the lowest quintile of vitamin D and the next quintile were 79 mL for FEV1 and 71 mL for FVC. In comparison, the differences between the highest and lowest quintiles of vitamin D were 126 mL for FEV1 and 172 mL for FVC. With further adjustment for physical activity, intake of vitamin D supplements and milk, and antioxidant level, the difference between the highest and lowest quintiles of vitamin D also was significant at 106 mL for FEV1 and 142 mL for FVC. In addition, an association between vitamin D and FEV1 was seen in non-Hispanic whites and blacks and was greater for those over 60 years and current or former smokers.
"The difference in lung function between the highest and lowest quintiles of vitamin D is substantial and greater than the difference between former and nonsmokers," said Dr. Black. "Although there is a definite relationship between lung function and vitamin D, it is unclear if increases in vitamin D through supplements or dietary intake will actually improve lung function in patients with chronic respiratory diseases."
Overall, male gender, younger age, white ethnicity, nonsmoking status, and regular, vigorous physical activity were associated with the highest lung function. Vitamin D was higher in men than women, was inversely related to BMI, and declined with age. Vitamin D also was lower in non-Hispanic blacks and Mexican-Americans, compared with non-Hispanic whites, and it was lower in participants smoking more than 20 cigarettes a day compared with nonsmokers.
"Vitamin D would be a relatively simple, low-cost intervention that would likely have high compliance to prevent or slow loss of lung function in susceptible subgroups. However, further studies examining the relationship between vitamin D and lung function are warranted to identify who may benefit from such an intervention," said author of the study's corresponding editorial Rosalind Wright, MD, MPH, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
"Chronic lung conditions compromise quality of life for millions of people in the United States and around the world," said W. Michael Alberts, MD, FCCP, President of the American College of Chest Physicians. "By understanding the effect that vitamins have on lung function, we may be able to identify new and more effective treatments for these debilitating diseases."
CHEST is a peer-reviewed journal published by the ACCP. It is available online each month at http://www.chestjournal.org . The ACCP represents 16,500 members who provide clinical respiratory, sleep, critical care, and cardiothoracic patient care in the United States and throughout the world. The ACCP's mission is to promote the prevention and treatment of diseases of the chest through leadership, education, research, and communication. For more information about the ACCP, please visit the ACCP Web site at http://www.chestnet.org . |